Setia Anugrah Medika

What Setia Anugrah Medika does

PT. Setia Anugrah Medika (operating as Setia Medika) is an Indonesian medical device distributor founded in 2002 and headquartered in Tanjung Priok, North Jakarta, that supplies clinical laboratory diagnostic instruments, reagents, and consumables to hospitals, clinical pathology laboratories, blood banks, and government health facilities across Indonesia. Its product portfolio spans the full diagnostic workflow, anchored by the AltaGel M/Pro/Star automated blood grouping analyzer family built on microcolumn gel immunoassay technology, complemented by proprietary gel card consumables (eight variants including ABO/Rh, Reverse, Coombs, and Neutral) and supporting incubators and centrifuges. Beyond blood banking, the company distributes clinical chemistry analyzers (AltaChem Pro, SM-230 at 200 tests/hour, SM-308 semi-automated), the Drawray iStar 500 chemiluminescence immunoassay system, the Labnovation LD-560 HPLC HbA1c analyzer, the YHLO UNICELL-S point-of-care testing platform, and a complete COVID-19 diagnostic suite including Real-Time PCR systems (Zeesan MA-6000), automated nucleic acid extraction (LEPU Nexor 32), rapid antigen and antibody tests, and virus transport media.

The company's business model combines one-time equipment sales with recurring revenue from proprietary reagents and consumables, supplemented by Field Service Engineer–led technical support and on-site maintenance. Distribution is multi-channel: direct enterprise field sales targeting hospitals and laboratories, government e-procurement via the LKPP and INAPROC catalogs, and regional representative offices in Semarang, Surabaya (with attached warehouse), and Bandung. Pricing is quote-based and not publicly disclosed, and products reach the market under multiple brands (AltaGel, AltaChem, Drawray, Labnovation, SM, YHLO, Zeesan, LEPU) sourced from manufacturers in China and other markets. The company operates warehouses in Jakarta (Green Sedayu Bizpark Cakung) and Surabaya/Sidoarjo, and built a 2,000 m² factory in the JABABEKA Cikarang industrial estate (late 2020) for domestic production of vacuum blood collection tubes and PCR reagents—marking a pivot from pure distribution toward vertical integration. Customer-facing activities include co-organized seminars and webinars with PDS PatKLIn (Indonesian Clinical Pathology Association) and BBLK/LITBANGKES-validated products carrying AKL marketing licenses from KEMENKES RI, with named customers including the Mitra Keluarga hospital group, RS Santosa Bandung, RS Zainoel Abidin Aceh, and government entities such as Dinas Kesehatan Kabupaten Bekasi and RSUD Deli Serdang.

Name

Setia Anugrah Medika

Legal name

PT. SETIA ANUGRAH MEDIKA

Website

https://setiamedika.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Setia Anugrah Medika is an Indonesian medical device distributor supplying clinical laboratory diagnostic instruments, reagents, and consumables—including blood grouping analyzers, chemistry analyzers, CLIA, HPLC, POCT, and PCR systems—to hospitals, clinical labs, and government health facilities across Indonesia.

Ownership category

akta.pro rank

Product category

Medical Device Distribution

NAICS

Medical Equipment and Supplies Manufacturing (3391), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• Medical device distribution
• Clinical diagnostics
• Laboratory equipment
• Blood grouping analyzers
• Reagent supply

Headquarters

HQ city

Tanjung Priok

HQ country

Indonesia

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Equipment Sales: Sale of clinical laboratory instruments including blood grouping analyzers, chemistry analyzers, CLIA systems, HPLC analyzers, and POCT platforms. Products sold with reagents and consumables packages.
2. Reagents and Consumables: Continuous revenue from proprietary reagents, test cards, gel cards, extraction kits, and consumables required for operation of sold instruments. Products available on government e-catalogs (LKPP, INAPROC).
3. Technical Support and Service: Field Service Engineer support, technical support services, and on-site maintenance services for installed equipment base across Indonesia.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

PT Setia Anugrah Medika distributes a comprehensive portfolio of medical laboratory diagnostic instruments, reagents, and consumables — including automated blood grouping analyzers (AltaGel series), clinical chemistry analyzers, chemiluminescence immunoassay systems, HPLC HbA1c analyzers, POCT platforms, real-time PCR and RNA extraction systems, COVID-19 rapid antigen/antibody tests, vacuum blood collection tubes, and gel cards — to hospitals, clinical laboratories, and government health facilities across Indonesia, supported by Field Service Engineers, technical support, and on-site maintenance.

Product overview

PT Setia Anugrah Medika is an Indonesian healthcare laboratory equipment distributor offering a comprehensive portfolio of diagnostic instruments and reagents. The core product lineup centers on the AltaGel automated blood grouping analyzer series (AltaGel M, Pro, Star) using microcolumn gel immunoassay technology, complemented by dedicated Gel Card consumables and supporting incubators/centrifuges. The company also distributes clinical chemistry analyzers (AltaChem Pro, SM-230, SM-308), chemiluminescence immunoassay systems (Drawray iStar 500), HPLC HbA1c analyzers (Labnovation LD-560), and POCT platforms (YHLO UNICELL-S). A significant product category includes COVID-19 diagnostic solutions comprising rapid antigen tests, real-time PCR systems, and RNA extraction instruments. The reagent portfolio spans hematology, clinical chemistry, coagulation, HPLC, immunology, blood grouping, and electrolyte testing across multiple analyzer platforms including DIRUI, TECO, YHLO, and ZENTECH brands.

Differentiator

Problem solved

Functional benefit

Products and services

• AltaGel M - Automated Blood Grouping Analyzer Automated blood grouping analyzer based on microcolumn gel immunoassay technology with 24 card/hour throughput for ABO reverse & forward grouping, Rh phenotyping, cross-matching, and irregular antibody screening, intended for hospital blood banks and clinical laboratories.
• AltaGel Pro - Automated Blood Grouping Analyzer High-throughput automated blood grouping analyzer using microcolumn gel immunoassay with 48 card/hour throughput, 96 sample positions, and dual sampling probes for high-volume blood bank operations.
• AltaGel Star - Automated Blood Grouping Analyzer High-capacity automated blood grouping analyzer with 72 card/hour throughput and 240 gel card positions for high-volume blood bank operations.
• Gel Card (Microcolumn Gel Immunoassay) Microcolumn gel immunoassay cards for blood grouping and crossmatch testing, available in 8 variants including ABO/Rh, Reverse, Neutral, Coombs, and Rh antigen cards, used as consumables with AltaGel analyzers.
• AltaGel I - Gel Card Incubator Gel card incubator with LED display and automatic timing control for antibody immunoreaction testing in blood bank workflows.
• AltaGel S - Medical Centrifuge Medical centrifuge designed for microcolumn gel cards with 3000 r/min maximum speed, 12-card capacity, and automatic balance detection for blood grouping applications.
• Drawray iStar 500 - Chemiluminescence Immunoassay Analyzer Automated chemiluminescence immunoassay (CLIA) analyzer with 36 tests/hour throughput and bi-directional LIS connectivity for multi-panel immunology testing, intended for hospital clinical laboratories.
• Labnovation LD-560 - HbA1c Analyzer Automated HbA1c analyzer using HPLC gold standard method with 90-second test speed, 20-tube sample capacity, and CV less than 2% precision for diabetes monitoring in clinical laboratories.
• AltaChem Pro - Auto Chemistry Analyzer Compact automated clinical chemistry analyzer with up to 120 tests/hour throughput for small to medium laboratories with limited space. AKL KEMENKES RI No. 20102320431, listed on LKPP e-catalog.
• SM-230 - Auto Clinical Chemistry Analyzer Automated clinical chemistry analyzer with 200 tests/hour throughput (350 with ISE) and bi-directional LIS/HIS connectivity for continuous 24-hour operation in clinical laboratories. AKL KEMENKES RI No. AKL 20102420265, listed on LKPP INAPROC e-catalog.
• SM 308 - Semi Auto Clinical Chemistry Analyzer Semi-automated clinical chemistry analyzer with 7-inch color touchscreen, 8-position incubation, thermal printer, and memory storage for up to 30,600 test results for smaller laboratories. AKL KEMENKES RI No. 20102420125, listed on LKPP e-catalog.
• BILMICROMETER AUTO 3 - Total Bilirubin Analyzer Rapid bilirubin analyzer for neonates measuring total bilirubin in 3 seconds with automatic hemolysis correction up to 250 mg/dl for hospital maternity and neonatal units.
• YHLO GLINE-2019-nCoV Ag - Rapid Antigen Test COVID-19 rapid antigen test with 96% sensitivity and 100% specificity using immunochromatographic method, providing qualitative detection in 15 minutes for healthcare facilities and screening programs. AKL KEMENKES RI No. AKL 20303120371.
• YHLO UNICELL-2019-nCoV Ag - Rapid Antigen Reagent COVID-19 antigen detection reagent using immunofluorescence method with YHLO UNICELL-S reader, achieving 91.18% sensitivity and 100% specificity for rapid screening in healthcare settings. AKL KEMENKES RI No. AKL 20303120564.
• YHLO UNICELL-S - POCT Platform Point-of-care testing platform using fluorescence immunochromatography for rapid diagnostics including cardiac markers, inflammation markers, hormones, diabetes, and bone metabolism with 15-minute test results for bedside and clinic-side use. AKL KEMENKES RI No. 20304120019.
• SM Blood Vacuum Tubes Complete line of vacuum blood collection tubes including K3EDTA (2ml, 3ml), Clot Activator (3ml, 5ml), Sodium Citrate 3.2% (1.8ml, 2.7ml), SST with Gel (4ml, 6ml), and Plain tubes (3ml, 5ml) for hospital and clinical laboratory use.
• Real-Time PCR & RNA Extraction Systems Complete PCR testing solutions including Zeesan MA-6000 Real-Time PCR instruments, LEPU Nexor 32 Fully Automated Nucleic Acid Extraction Systems, and associated PCR and extraction reagents for COVID-19 and other infectious disease testing in hospital and government laboratories.

Quantifiable outcome

• COVID-19 diagnostic equipment distributed to 663+ healthcare facilities across Indonesia
• +1 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core.

• INAEQAS & PDS PatKLIncoreGTM or Marketing Partner · 24 April 2026PT Setia Anugrah Medika participated in ACQALM 2026 organized by INAEQAS & PDS PatKLIn at Hotel Padma, Semarang (April 24-25, 2026), showcasing their diagnostic products to laboratory professionals.
• PDS PatKLIncoreGTM or Marketing Partner · 22 October 2025PT Setia Anugrah Medika participated in KONAS XII & PIT XXIV organized by PDS PatKLIn at Hotel Santika Premiere Dyandra, Medan (October 22-24, 2025).
• PDS PatKLIncoreGTM or Marketing Partner · 26 July 2025PT Setia Anugrah Medika participated in SSAM (Sumatera Scientific Annual Meeting) XIV organized by PDS PatKLIn at BW Luxury Hotel, Jambi (July 26-27, 2025).
• PDS PatKLIncoreGTM or Marketing Partner · 18 July 2024PT Setia Anugrah Medika participated in SSAM XIII organized by PDS PatKLIn at Universitas Syiah Kuala, Banda Aceh (July 18-19, 2024).
• Badan Penelitian dan Pengembangan Kesehatan (LITBANGKES) KEMENKES RIcoreStrategic or Co-development Partner · 17 May 2021LITBANGKES conducted validation testing for YHLO UNICELL-S Neutralizing Antibody (NAb) reagent for POCT platform.
• Badan Penelitian dan Pengembangan Kesehatan (LITBANGKES) KEMENKES RIcoreStrategic or Co-development Partner · 11 May 2021LITBANGKES conducted validation testing for YHLO iFlash Neutralizing Antibody (NAb) reagent in collaboration with PT Setia Anugrah Medika.
• PDS PatKLIn cabang SurabayacoreGTM or Marketing Partner · 4 May 2021PT Setia Anugrah Medika co-organized webinar on SARS-CoV2 Neutralizing Antibody (NAb) with PDS PatKLIn Surabaya branch, theme 'LABORATORY ASPECT FOR IMMUNITY AGAINTS COVID-19'.
• PDS PatKLIn cabang MedancoreGTM or Marketing Partner · 10 April 2021PT Setia Anugrah Medika co-organized seminar on Neutralizing Antibody (NAb) testing post-COVID-19 vaccination with PDS PatKLIn Medan branch, attended by 500+ participants.
• PDS PatKLIn cabang MedancoreGTM or Marketing Partner · 6 April 2021Joint seminar on Neutralizing Antibody (NAb) examination and its relation to ongoing COVID-19 vaccination with theme 'PERFORMANCE NEUTRALIZING ANTIBODIES AFTER VACCINATION AND IT'S LABORATORY TEST'.
• Balai Besar Laboratorium Kesehatan (BBLK)coreStrategic or Co-development Partner · 17 March 2021BBLK conducted product validation testing for YHLO GLINE rapid antigen test, confirming 100% sensitivity and 100% specificity at CT≤25. Results approved by KEMENKES RI.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• PT Sysmex Indonesia: Indonesian subsidiary of Sysmex Corporation (Japan) distributing hematology, coagulation, and clinical chemistry analyzers and reagents to Indonesian hospitals and laboratories. Most directly comparable to Setia's IVD/laboratory diagnostic equipment distribution business with overlapping customer base.
• PT Mindray Medical Indonesia: Indonesian operation of Shenzhen Mindray Bio-Medical Electronics, distributing a broad IVD and patient monitoring portfolio (hematology, chemistry, immunoassay) to Indonesian hospitals. Closely comparable product overlap to Setia, particularly on Chinese-OEM-sourced analyzers.
• PT Bio-Rad Laboratories Indonesia: Indonesian arm of Bio-Rad Laboratories distributing quality controls, IVD reagents, and clinical diagnostics instruments. Comparable to Setia's distribution of immunoassay, blood banking reagents, and laboratory consumables across Indonesian clinical labs.
• PT Enseval Putera Megatrading: Indonesian publicly-listed pharmaceutical and medical equipment distributor (IDX ticker: EPMT) with nationwide logistics network. Comparable as a medical distribution business serving Indonesian hospitals and pharmacies, though with broader pharma scope than Setia's diagnostic focus.
• PT Sinar Roda Utama: Indonesian medical device and hospital equipment distributor supplying diagnostic instruments, consumables, and laboratory accessories to hospitals and clinics. Comparable mid-sized local distributor with similar target customer base and government procurement channel exposure.
• PT Global Medisindo: Indonesian medical device distributor focused on laboratory diagnostic equipment and reagents serving hospital and clinical laboratory customers. Directly comparable as a domestic IVD/laboratory equipment distributor targeting similar customer segments in Indonesia.

Broad incumbents

• PT Abbott Indonesia (Diagnostics): Indonesian subsidiary of Abbott distributing a broad diagnostics portfolio (architect immunoassay, hematology, molecular) plus nutrition and devices. Large multinational incumbent with overlapping diagnostic categories but a much wider portfolio than Setia's mid-market focus.
• PT Roche Indonesia (Diagnostics): Indonesian operation of F. Hoffmann-La Roche distributing cobas immunoassay/chemistry analyzers and PCR systems. Comparable in IVD distribution but operates as part of a global multinational with broader resources and enterprise-tier customer focus.
• PT Kimia Farma Trading & Distribution: Distribution arm of state-owned PT Kimia Farma, distributing pharmaceuticals, medical devices, and laboratory supplies across Indonesia via government and private channels. Comparable distribution scale and government procurement exposure, though with broader pharma mandate.

Emerging players

• HORIBA Medical: Hematology and clinical chemistry analyzer manufacturer with distribution into Indonesian hospital labs. Comparable product overlap on hematology analyzers and reagents sold to the same clinical pathology customer segment that Setia serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@setiaanugrahmedika
• Facebookfacebook.com/ptsetianugrahmedika
• Instagraminstagram.com/ptsetiaanugrahmedika
• LinkedInlinkedin.com/company/pt-setia-anugrah-medika

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Setia Anugrah Medika